PolyHeal® Micro belongs to a new category of products for wound management, due to its unique and innovative mechanism of action, based on Negatively-Charged Microsphere (NCM) Technology.
PolyHeal® Micro is a liquid suspension that facilitates an easy topical application, making it a suitable therapy for both in-hospital and outpatient treatment. It can even be applied by the own patient under the supervision of a healthcare professional, thus reducing length of stay and allowing them to get back to their daily life as soon as possible.
It is indicated in the treatment of hard-to-heal ulcers of different etiologies, reactivating the wound-healing process and accelerating the granulation tissue production, even in wounds with exposed bones and tendons. It has also shown excellent results after 4 weeks of use, reducing treatment time, making possible a reduction in the economic burden on the healthcare system and improving the patient quality of life.1
REACTIVATES HEALING
And accelerates the formation of granulation tissue favoring closure.
SWITCHES THE WOUND FROM THE INFLAMMATORY
To the proliferative phase, leading to patient’s own cells to reactivate the healing process.
REMARKABLE EFFICACY
In exposed bones and tendons including stagnant hard to heal wounds.
PROVEN LONG TERM EFFICACY AND SAFETY
Reduction in wound care expenditure and hospitalization burdens.
PolyHeal® Micro is a class IIb medical device with CE marking that was launched internationally in 2017 and complements Praxis Pharmaceutical’s advanced wound care portfolio.
